Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

97 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Serial enumeration of circulating tumor cells predicts treatment response and prognosis in metastatic breast cancer: a prospective study in 393 patients.
Wallwiener M, Riethdorf S, Hartkopf AD, Modugno C, Nees J, Madhavan D, Sprick MR, Schott S, Domschke C, Baccelli I, Schönfisch B, Burwinkel B, Marmé F, Heil J, Sohn C, Pantel K, Trumpp A, Schneeweiss A. Wallwiener M, et al. Among authors: nees j. BMC Cancer. 2014 Jul 11;14:512. doi: 10.1186/1471-2407-14-512. BMC Cancer. 2014. PMID: 25015676 Free PMC article.
Plasma hyaluronic acid level as a prognostic and monitoring marker of metastatic breast cancer.
Peng C, Wallwiener M, Rudolph A, Ćuk K, Eilber U, Celik M, Modugno C, Trumpp A, Heil J, Marmé F, Madhavan D, Nees J, Riethdorf S, Schott S, Sohn C, Pantel K, Schneeweiss A, Chang-Claude J, Yang R, Burwinkel B. Peng C, et al. Among authors: nees j. Int J Cancer. 2016 May 15;138(10):2499-509. doi: 10.1002/ijc.29975. Epub 2016 Feb 16. Int J Cancer. 2016. PMID: 26686298
Plasma S100P level as a novel prognostic marker of metastatic breast cancer.
Peng C, Chen H, Wallwiener M, Modugno C, Cuk K, Madhavan D, Trumpp A, Heil J, Marmé F, Nees J, Riethdorf S, Schott S, Sohn C, Pantel K, Schneeweiss A, Yang R, Burwinkel B. Peng C, et al. Among authors: nees j. Breast Cancer Res Treat. 2016 Jun;157(2):329-338. doi: 10.1007/s10549-016-3776-1. Epub 2016 May 4. Breast Cancer Res Treat. 2016. PMID: 27146585
Impact of apoptotic circulating tumor cells (aCTC) in metastatic breast cancer.
Deutsch TM, Riethdorf S, Nees J, Hartkopf AD, Schönfisch B, Domschke C, Sprick MR, Schütz F, Brucker SY, Stefanovic S, Sohn C, Pantel K, Trumpp A, Schneeweiss A, Wallwiener M. Deutsch TM, et al. Among authors: nees j. Breast Cancer Res Treat. 2016 Nov;160(2):277-290. doi: 10.1007/s10549-016-3997-3. Epub 2016 Oct 1. Breast Cancer Res Treat. 2016. PMID: 27696083
Sustained prognostic impact of circulating tumor cell status and kinetics upon further progression of metastatic breast cancer.
Jauch SF, Riethdorf S, Sprick MR, Schütz F, Schönfisch B, Brucker SY, Deutsch TM, Nees J, Saini M, Becker LM, Burwinkel B, Sinn P, Marmé F, Pantel K, Jäger D, Sohn C, Trumpp A, Wallwiener M, Schneeweiss A. Jauch SF, et al. Among authors: nees j. Breast Cancer Res Treat. 2019 Jan;173(1):155-165. doi: 10.1007/s10549-018-4972-y. Epub 2018 Oct 1. Breast Cancer Res Treat. 2019. PMID: 30276763
97 results